Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
In order to use this website we use the following technically required cookies
PHPSESSID
wordpress_test_cookie
wordpress_logged_in_
wordpress_sec_
wp-settings-
wp-settings-time-
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
